BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2378923)

  • 1. A possible role of hippocampal dysfunction in schizophrenic symptomatology.
    Luchins DJ
    Biol Psychiatry; 1990 Jul; 28(2):87-91. PubMed ID: 2378923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two types of motivation revealed by ibotenic acid nucleus accumbens lesions: dissociation of food carrying and hoarding and the role of primary and incentive motivation.
    Whishaw IQ; Kornelsen RA
    Behav Brain Res; 1993 Jun; 55(2):283-95. PubMed ID: 8357531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis].
    Gattaz WF; Brunner J; Schmitt A; Maras A
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):489-96. PubMed ID: 7835820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary-adrenal and dopaminergic modulation of schedule-induced polydipsia: behavioral and neurochemical evidence.
    Mittleman G; Blaha CD; Phillips AG
    Behav Neurosci; 1992 Apr; 106(2):408-20. PubMed ID: 1590958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric rotational (circling) behavior, a dopamine-related asymmetry: preliminary findings in unmedicated and never-medicated schizophrenic patients.
    Bracha HS
    Biol Psychiatry; 1987 Aug; 22(8):995-1003. PubMed ID: 3607140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine release in the nucleus accumbens: the perspective from aberrations of consciousness in schizophrenia.
    Gray JA
    Neuropsychologia; 1995 Sep; 33(9):1143-53. PubMed ID: 7501135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical, hippocampal, and striatal mediation of schedule-induced behaviors.
    Mittleman G; Whishaw IQ; Jones GH; Koch M; Robbins TW
    Behav Neurosci; 1990 Jun; 104(3):399-409. PubMed ID: 2354035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation.
    Salamone JD
    Behav Brain Res; 1994 Apr; 61(2):117-33. PubMed ID: 8037860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicated chronic schizophrenic patients do not demonstrate left turning asymmetry.
    Levine J; Martine T; Feraro R; Kimhi R; Bracha HS
    Neuropsychobiology; 1997; 36(1):22-4. PubMed ID: 9211440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia.
    Gray JA; Joseph MH; Hemsley DR; Young AM; Warburton EC; Boulenguez P; Grigoryan GA; Peters SL; Rawlins JN; Taib CT
    Behav Brain Res; 1995 Nov; 71(1-2):19-31. PubMed ID: 8747172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesolimbic Dopamine and the Regulation of Motivated Behavior.
    Salamone JD; Pardo M; Yohn SE; López-Cruz L; SanMiguel N; Correa M
    Curr Top Behav Neurosci; 2016; 27():231-57. PubMed ID: 26323245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of certain behavioral changes after hippocampal damage and their alteration by dopaminergic intervention into nucleus accumbens.
    Reinstein DK; Hannigan JH; Isaacson RL
    Pharmacol Biochem Behav; 1982 Aug; 17(2):193-202. PubMed ID: 7134232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prefrontal lesion reverses abnormal mesoaccumbens response in an animal model of schizophrenia.
    Goto Y; O'Donnell P
    Biol Psychiatry; 2004 Jan; 55(2):172-6. PubMed ID: 14732597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective deficits in spatial working memory in the neonatal ventral hippocampal lesion rat model of schizophrenia.
    Brady AM; Saul RD; Wiest MK
    Neuropharmacology; 2010 Dec; 59(7-8):605-11. PubMed ID: 20732335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydipsia and hippocampal pathology.
    Umbricht D
    Biol Psychiatry; 1994 Nov; 36(10):709-10. PubMed ID: 7880943
    [No Abstract]   [Full Text] [Related]  

  • 16. Loss of the Kamin blocking effect in acute but not chronic schizophrenics.
    Jones SH; Gray JA; Hemsley DR
    Biol Psychiatry; 1992 Nov; 32(9):739-55. PubMed ID: 1360261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal signal transmission to the pedunculopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens: an electrophysiological and behavioural study.
    Yang CR; Mogenson GJ
    Neuroscience; 1987 Dec; 23(3):1041-55. PubMed ID: 2963972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.
    de Bruin NM; Ellenbroek BA; van Luijtelaar EL; Cools AR; Stevens KE
    Neuroscience; 2001; 105(1):169-80. PubMed ID: 11483310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology, phenomenology and the dopamine hypothesis of schizophrenia.
    McKenna PJ
    Br J Psychiatry; 1987 Sep; 151():288-301. PubMed ID: 3322465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.